Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1139443

registered interest
date	16/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to his oral evidence at the Health and Social Care Committee on 9 July 2019, what the expiration date is for the options on the additional transport capacity for medicines; what the timescales are for exercising those options; and what the cost to the Department will be if those options are not exercised.
tabling member constituency	Cambridge
tabling member printed	Daniel Zeichner
uin	277758
answer	answer is ministerial correction date of answer 22/07/2019 answer text <p>The details of the contract notices, specification and contract conditions associated with the procurement of contingency freight solutions for medicines and medical products is currently being finalised as part of the pre-procurement market engagement being conducted ahead of publication.</p><p>The terms and conditions associated with the procurement exercises will be available in conjunction with the contract notice publication, to inform potential bidders.</p><p> </p><p> </p><p> </p><p><strong> </strong></p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 22/07/2019 15:44:39 answering member 1585 label Biography information for Stephen Hammond
tabling member	4382 label Biography information for Daniel Zeichner

1139444

registered interest
date	16/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to his oral evidence at the Health and Social Care Committee on 9 July 2019, if he will place in the Library his Department’s latest assessment of (a) the appropriate level of warehousing capacity required for stockpiling medicines and (b) the flow assumptions of importing medicines in the event that the UK leaves the EU without a deal.
tabling member constituency	Cambridge
tabling member printed	Daniel Zeichner
uin	277759
answer	answer is ministerial correction date of answer 23/07/2019 answer text <p>To ensure sufficient space to store stockpiled medicines, we agreed contracts for additional warehouse space, including ambient, refrigerated and controlled drug storage aligned to the possible 29 March exit date. All these types of storage remain available and should be sufficient to meet the additional needs of medicines suppliers to enable them to build or rebuild their stockpiles prior to 31 October. The original procurement was carried out to give additional leeway should the level of storage required be greater than initially estimated. As part our contingency planning for a possible ‘no deal’ European Union exit on 31 October, we have re-assessed the additional warehouse capacity required to meet the six-week stockpile request made of industry and have confidence that the current capacity we have in place for 31 October will be sufficient.</p><p>The Government’s Border Delivery Group has been reviewing the readiness of border infrastructures and of traders to comply with customs and borders processes in the United Kingdom and the EU. While the predicted flow rate across the short straits has improved slightly since 29 March, significant disruption would be expected for six months following a ‘no deal’ exit, with the most severe period being the first three months.</p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 23/07/2019 15:30:00 answering member 1585 label Biography information for Stephen Hammond
tabling member	4382 label Biography information for Daniel Zeichner

1139445

registered interest
date	16/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the effect of the stockpiling of goods for sale at Christmas on warehouse capacity for medicines before the UK leaves the EU on 31 October.
tabling member constituency	Cambridge
tabling member printed	Daniel Zeichner
uin	277760
answer	answer is ministerial correction date of answer 22/07/2019 answer text <p>As part our contingency planning for 31 October possible ‘no deal’ European Union exit, we have assessed the additional warehouse capacity required to meet the six-week stockpile request made of industry and have confidence that the capacity we have in place for 31 October will be sufficient.</p><p>Our assessment includes potential seasonal fluctuations in demand for medicines, and the storage is secured through to December so it will not be affected by the additional storage required for Christmas goods.</p><p><strong> </strong></p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 22/07/2019 15:46:49 answering member 1585 label Biography information for Stephen Hammond
tabling member	4382 label Biography information for Daniel Zeichner

1136246

registered interest
date	02/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what discussions he has had with his EU counterparts on the supply of medicines from other EU member states in the event that the UK leaves the EU without an agreement.
tabling member constituency	Ceredigion
tabling member printed	Ben Lake
uin	272242
answer	answer is ministerial correction date of answer 10/07/2019 answer text <p>The Government maintains that leaving the European Union with a deal is the best exit outcome and has strongly expressed its opposition to leaving without a deal, in line with the position consistently expressed by Parliament. However, leaving without a deal on 31 October 2019 remains the legal default at the end of the Article 50 extension period if no withdrawal agreement is agreed. Therefore, as a responsible Government, we will continue to prepare to minimise any disruption to the supply of medicines and medical products in a ‘no deal’ scenario.</p><p> </p><p>The Department continues to work closely with the devolved administrations, relevant EU member states, industry trade bodies and suppliers, the National Health Service and our other main stakeholders to ensure that we are prepared for leaving the EU without a deal in October.</p><p>On 26 June, we wrote to suppliers of medicines to the United Kingdom from or via the EU or European Economic Area setting out our continuing multi-layered approach to ensure the continuity of supply of all medicines and medical products in a potential ‘no deal’ scenario on 31 October. Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a></p><p>We recognise that suppliers may incur additional storage costs for stockpiling medicines or switching to air freight We have been working closely with industry to minimise costs and support medicine suppliers taking part in the contingency programme.</p><p>The provision for additional warehouse space procured for a possible 29 March ‘no deal’ exit remains available for the 31 October deadline. The Department expects to spend around £11 million over the life of these contracts.</p><p> </p><p> </p><p> </p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 272243 272244 272245 272246 question first answered 10/07/2019 16:43:54 answering member 1585 label Biography information for Stephen Hammond
tabling member	4630 label Biography information for Ben Lake

1136247

registered interest
date	02/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential effect on the ability of suppliers of medicines based in the EU to maintain medical supplies to the UK in the event that the UK leaves the EU.
tabling member constituency	Ceredigion
tabling member printed	Ben Lake
uin	272243
answer	answer is ministerial correction date of answer 10/07/2019 answer text <p>The Government maintains that leaving the European Union with a deal is the best exit outcome and has strongly expressed its opposition to leaving without a deal, in line with the position consistently expressed by Parliament. However, leaving without a deal on 31 October 2019 remains the legal default at the end of the Article 50 extension period if no withdrawal agreement is agreed. Therefore, as a responsible Government, we will continue to prepare to minimise any disruption to the supply of medicines and medical products in a ‘no deal’ scenario.</p><p> </p><p>The Department continues to work closely with the devolved administrations, relevant EU member states, industry trade bodies and suppliers, the National Health Service and our other main stakeholders to ensure that we are prepared for leaving the EU without a deal in October.</p><p>On 26 June, we wrote to suppliers of medicines to the United Kingdom from or via the EU or European Economic Area setting out our continuing multi-layered approach to ensure the continuity of supply of all medicines and medical products in a potential ‘no deal’ scenario on 31 October. Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a></p><p>We recognise that suppliers may incur additional storage costs for stockpiling medicines or switching to air freight We have been working closely with industry to minimise costs and support medicine suppliers taking part in the contingency programme.</p><p>The provision for additional warehouse space procured for a possible 29 March ‘no deal’ exit remains available for the 31 October deadline. The Department expects to spend around £11 million over the life of these contracts.</p><p> </p><p> </p><p> </p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 272242 272244 272245 272246 question first answered 10/07/2019 16:43:55 answering member 1585 label Biography information for Stephen Hammond
tabling member	4630 label Biography information for Ben Lake

1136248

registered interest
date	02/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what discussions he has had with his European Union counterparts on the maintenance of supply of medicines from the EU to the UK in the event that the UK leaves the EU without a deal.
tabling member constituency	Ceredigion
tabling member printed	Ben Lake
uin	272244
answer	answer is ministerial correction date of answer 10/07/2019 answer text <p>The Government maintains that leaving the European Union with a deal is the best exit outcome and has strongly expressed its opposition to leaving without a deal, in line with the position consistently expressed by Parliament. However, leaving without a deal on 31 October 2019 remains the legal default at the end of the Article 50 extension period if no withdrawal agreement is agreed. Therefore, as a responsible Government, we will continue to prepare to minimise any disruption to the supply of medicines and medical products in a ‘no deal’ scenario.</p><p> </p><p>The Department continues to work closely with the devolved administrations, relevant EU member states, industry trade bodies and suppliers, the National Health Service and our other main stakeholders to ensure that we are prepared for leaving the EU without a deal in October.</p><p>On 26 June, we wrote to suppliers of medicines to the United Kingdom from or via the EU or European Economic Area setting out our continuing multi-layered approach to ensure the continuity of supply of all medicines and medical products in a potential ‘no deal’ scenario on 31 October. Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a></p><p>We recognise that suppliers may incur additional storage costs for stockpiling medicines or switching to air freight We have been working closely with industry to minimise costs and support medicine suppliers taking part in the contingency programme.</p><p>The provision for additional warehouse space procured for a possible 29 March ‘no deal’ exit remains available for the 31 October deadline. The Department expects to spend around £11 million over the life of these contracts.</p><p> </p><p> </p><p> </p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 272242 272243 272245 272246 question first answered 10/07/2019 16:43:55 answering member 1585 label Biography information for Stephen Hammond
tabling member	4630 label Biography information for Ben Lake

1136249

registered interest
date	02/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect on the finances of medicine suppliers in the UK of stockpiling an additional six weeks supply of medicines in the event that the UK leaves the EU without a deal.
tabling member constituency	Ceredigion
tabling member printed	Ben Lake
uin	272245
answer	answer is ministerial correction date of answer 10/07/2019 answer text <p>The Government maintains that leaving the European Union with a deal is the best exit outcome and has strongly expressed its opposition to leaving without a deal, in line with the position consistently expressed by Parliament. However, leaving without a deal on 31 October 2019 remains the legal default at the end of the Article 50 extension period if no withdrawal agreement is agreed. Therefore, as a responsible Government, we will continue to prepare to minimise any disruption to the supply of medicines and medical products in a ‘no deal’ scenario.</p><p> </p><p>The Department continues to work closely with the devolved administrations, relevant EU member states, industry trade bodies and suppliers, the National Health Service and our other main stakeholders to ensure that we are prepared for leaving the EU without a deal in October.</p><p>On 26 June, we wrote to suppliers of medicines to the United Kingdom from or via the EU or European Economic Area setting out our continuing multi-layered approach to ensure the continuity of supply of all medicines and medical products in a potential ‘no deal’ scenario on 31 October. Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a></p><p>We recognise that suppliers may incur additional storage costs for stockpiling medicines or switching to air freight We have been working closely with industry to minimise costs and support medicine suppliers taking part in the contingency programme.</p><p>The provision for additional warehouse space procured for a possible 29 March ‘no deal’ exit remains available for the 31 October deadline. The Department expects to spend around £11 million over the life of these contracts.</p><p> </p><p> </p><p> </p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 272242 272243 272244 272246 question first answered 10/07/2019 16:43:55 answering member 1585 label Biography information for Stephen Hammond
tabling member	4630 label Biography information for Ben Lake

1136250

registered interest
date	02/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how much his Department spent from the public purse on additional warehouse space to stockpile medicines in advance of (a) the 29 March 2019 and (b) the 31 October 2019 deadline to prepare for the UK leaving the EU without a deal.
tabling member constituency	Ceredigion
tabling member printed	Ben Lake
uin	272246
answer	answer is ministerial correction date of answer 10/07/2019 answer text <p>The Government maintains that leaving the European Union with a deal is the best exit outcome and has strongly expressed its opposition to leaving without a deal, in line with the position consistently expressed by Parliament. However, leaving without a deal on 31 October 2019 remains the legal default at the end of the Article 50 extension period if no withdrawal agreement is agreed. Therefore, as a responsible Government, we will continue to prepare to minimise any disruption to the supply of medicines and medical products in a ‘no deal’ scenario.</p><p> </p><p>The Department continues to work closely with the devolved administrations, relevant EU member states, industry trade bodies and suppliers, the National Health Service and our other main stakeholders to ensure that we are prepared for leaving the EU without a deal in October.</p><p>On 26 June, we wrote to suppliers of medicines to the United Kingdom from or via the EU or European Economic Area setting out our continuing multi-layered approach to ensure the continuity of supply of all medicines and medical products in a potential ‘no deal’ scenario on 31 October. Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a></p><p>We recognise that suppliers may incur additional storage costs for stockpiling medicines or switching to air freight We have been working closely with industry to minimise costs and support medicine suppliers taking part in the contingency programme.</p><p>The provision for additional warehouse space procured for a possible 29 March ‘no deal’ exit remains available for the 31 October deadline. The Department expects to spend around £11 million over the life of these contracts.</p><p> </p><p> </p><p> </p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 272242 272243 272244 272245 question first answered 10/07/2019 16:43:55 answering member 1585 label Biography information for Stephen Hammond
tabling member	4630 label Biography information for Ben Lake

1135245

registered interest
date	27/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether any companies based in the EU have indicated a wish to cancel contracts to supply the NHS with drugs in the event of the UK leaving the EU without a deal.
tabling member constituency	Wokingham
tabling member printed	John Redwood
uin	270230
answer	answer is ministerial correction date of answer 05/07/2019 answer text <p>The Department has been in contact with NHS England’s Commercial Medicines Unit (CMU), who puts in place competitively tendered arrangements (Framework Agreements) through which National Health Service hospital trusts can purchase certain medicines.</p><p>Neither the Department nor CMU are aware of any contract cancellations related to a ‘no deal’ European Union exit.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 05/07/2019 09:00:56 answering member 1585 label Biography information for Stephen Hammond
tabling member	14 label Biography information for Sir John Redwood

1134036

registered interest
date	24/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the availablity of (a) critical and (b) short shelf-life medicines in the event of the UK leaving the EU without a deal.
tabling member constituency	Coatbridge, Chryston and Bellshill
tabling member printed	Hugh Gaffney
uin	268516
answer	answer is ministerial correction date of answer 02/07/2019 answer text <p>The Government fully understands that maintaining access to all medicines and medical products, including critical medicines and short shelf-life products, is vitally important to millions of people in this country. Ensuring unhindered supply of these products remains the Government’s top priority.</p><p> </p><p>As in preparation for 29 March and 12 April, our ‘no deal’ EU Exit contingency plans for 31 October will cover the NHS, social care and the independent sector and covers all medicines, medical devices and clinical consumables, supplies for clinical trials, vaccines and countermeasures, and organs and tissues for transplants.</p><p>The Department has continued to work closely with the Devolved Administrations, industry trade bodies and suppliers, the NHS and other key stakeholders. Prior to 29 March, the Department analysed the supply chains of 12,300 medicines, close to half a million product lines of medical devices and clinical consumables, vaccines used in national and local programmes, and essential non-clinical goods on which the health and care system relies. These analyses and assessments have been updated where necessary and will continue to be refined while a ‘no deal’ EU Exit remains a possibility. This work has informed our plans.</p><p>We are asking suppliers to analyse their supply chains and to make alternative plans if they anticipate disruption, including rerouting to alternative ports or using airfreight where necessary. Our contingency measures aim to support industry-led measures and, where required, act as a ‘last resort’ to be used only when a supplier’s alternative arrangements encounter difficulties, to ensure uninterrupted supply.</p><p>In the case of medicines that cannot be stockpiled because, for example, they have short shelf-lives, such as medical radioisotopes, we are working closely with suppliers to make alternative arrangements using airfreight.</p><p>Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a></p><p>While we never give guarantees, we are confident that, if everyone – including suppliers, freight companies, international partners and the health and care system – does what they need to do, the supply of medicines and medical products should be uninterrupted in the event of a no-deal EU Exit.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 02/07/2019 11:33:39 answering member 1585 label Biography information for Stephen Hammond
tabling member	4614 label Biography information for Hugh Gaffney